A

Aquila Capital

674 employees

Aquila Capital is provides institutional investors worldwide with alternative investments solutions in real assets and private markets.

Investor insights

Sectors invested in

Therapeutics1
Oncology1
Rare Diseases1
Antibody based medicines1
Immune Thrombocytopenia1
Immunotherapy1
Immunology1
Autoimmune diseases1
Acute Myeloid Leukemia1
Biotechnology1
Pemphigus Vulgaris1
Clinical Trials1
high-risk myelodysplastic syndromes1
Myasthenia Gravis1
chronic inflammatory demyelinating polyneuropathy1

Funding rounds participated in

$72M sweet spot round size

Most of their 2 investments are in rounds between $33M and $110M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

alternative investments
asset management
Transformation Award
wind energy
storage
agriculture
real assets
solar PV
green logistics
Wind Energy
ESG
Agriculture
impact investment
hydropower
real estate
energy transition
battery storage
sustainable investment
sustainability
green energy
renewable energies
Real Estate
infrastructure
investment management
forestry
Logistics

Date founded

2001

Investments made

U

Undisclosed raised $110M on January 3, 2019

Investors: Trifecta Capital, HDFC Bank, CapitalG, Hillhouse Capital Management and Aquila Capital

a

argenx raised $33M on June 3, 2016

Investors: Burrage Capital Management, DAFNA Capital Management, LLC, MPM Capital and Aquila Capital

FAQ